Advertisement
Advertisement

EVO

EVO logo

Evotec SE - ADR

2.61
USD
Sponsored
-0.08
-2.97%
Jun 17, 15:59 UTC -4
Closed
exchange

After-Market

2.69

+0.08
+2.87%

Evotec SE - ADR Profile

About

EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries

Info & Links

CEO

Christian Wojczewski

Headquarters

ESSENER BOGEN 7
HAMBURG, 2M 22419, GERMANY

Industry

Medical Drugs

Sector

Medical

Website

www.evotec.com

Auditor

BDO AG, Wirtschaftspr�fungsgesellschaft

Share holders

--

Employees

4,553

Evotec SE - ADR Statistics

Valuation Measures

Market Capitalization2

953.68M

Enterprise Value

849.44M

Enterprise Value/EBITDA(ttm)

-4.60

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.12

Price to Book(mrq)

1.01

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

12.34%

Operating Margin(ttm)

-21.24%

Profit Margin(ttm)

-15.52%

Return on Equity(ttm)

-18.20%

Return on Invested Capital(ttm)

-8.41%

Return on Assets(ttm)

-8.58%

Income Statement

Revenue(ttm)

864.62M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

98.71M

EBITDA(ttm)3

-184.61M

Net Income Available to Common(ttm)

-226.57M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.92

52-Week Change

-36.80%

S&P 500 52-Week Change

24.03%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

351.94M

% Held by Insiders

1.00%

% Held by Institutions

5.81%

Balance Sheet

Total Cash(mrq)

520.55M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

349.77M

Total Debt/Equity(mrq)

55.15%

Current Ratio(mrq)

2.07%

Quick Ratio(mrq)

2.03%

Book Value Per Share(mrq)

2.59

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.03

Free Cash Flow(ytd)

-92.22M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement